Simplex Trading
ROIV icon

Simplex Trading’s Roivant Sciences ROIV Stock Holding History

Simplex Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Sell
73,000
-123,300
-63% -$3.17M ﹤0.01% 1808
2025
Q4 		$4.26M Sell
196,300
-104,700
-35% -$2.07M ﹤0.01% 1403
2025
Q3 		$4.55M Buy
301,000
+171,800
+133% +$2.13M ﹤0.01% 1550
2025
Q2 		$1.46M Sell
129,200
-172,800
-57% -$1.87M ﹤0.01% 2404
2025
Q1 		$3.05M Buy
302,000
+122,900
+69% +$1.33M ﹤0.01% 1652
2024
Q4 		$2.12M Sell
179,100
-57,200
-24% -$676K ﹤0.01% 2142
2024
Q3 		$2.73M Sell
236,300
-28,200
-11% -$321K ﹤0.01% 2001
2024
Q2 		$2.79M Buy
264,500
+101,900
+63% +$1.12M ﹤0.01% 1911
2024
Q1 		$1.71M Sell
162,600
-251,300
-61% -$2.71M ﹤0.01% 2564
2023
Q4 		$4.65M Buy
413,900
+259,100
+167% +$2.53M ﹤0.01% 1620
2023
Q3 		$1.81M Buy
154,800
+134,700
+670% +$1.52M ﹤0.01% 2159
2023
Q2 		$202K Sell
20,100
-9,800
-33% -$87.7K ﹤0.01% 4283
2023
Q1 		$220K Buy
29,900
+23,600
+375% +$194K ﹤0.01% 4208
2022
Q4 		$50K Sell
6,300
-3,900
-38% -$21.7K ﹤0.01% 5906
2022
Q3 		$32K Sell
10,200
-3,000
-23% -$11.6K ﹤0.01% 6996
2022
Q2 		$53K Buy
13,200
+5,900
+81% +$23.4K ﹤0.01% 6419
2022
Q1 		$36K Buy
+7,300
New +$48.1K ﹤0.01% 7581

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ROIV Position: Q1 2026 in Review

Simplex Trading reduced its Roivant Sciences (ROIV) stake by 39% in Q1 2026, selling an estimated $1.44M and leaving 88,035 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Simplex Trading first reported a position in ROIV in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.12M in Q4 2025. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Simplex Trading held 88,035 shares of Roivant Sciences worth $2.44M as of Q1 2026.
  • Simplex Trading sold 55,862 Roivant Sciences shares in Q1 2026, an estimated $1.44M.
  • Roivant Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #1667 holding.
  • Simplex Trading first reported a position in Roivant Sciences in Q1 2022 and has held it in 12 quarters since.
  • Simplex Trading's Roivant Sciences position peaked at $3.12M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.